| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/06/2010 | EP2139508A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/06/2010 | EP2139492A1 Methods for treating neovascular ocular diseases |
| 01/06/2010 | EP2139488A1 Use of riboflavin in the treatment of hypertension |
| 01/06/2010 | EP2139480A1 Ranolazine for enhancing insulin secretion |
| 01/06/2010 | EP2139472A1 Tetrahydroindole derivatives as nadph oxidase inhibitors |
| 01/06/2010 | EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 01/06/2010 | EP1957490B1 Novel indolizine derivatives, method for preparing same and therapeutic compositions comprising same |
| 01/06/2010 | EP1062948B1 Remedies for non cardiogenic diastolic dysfunction |
| 01/06/2010 | EP1005361B1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ENDOTHELIAL DYSFUNKTION AND FOR THE INHIBITION OF ANGIOGENESIS RESPECTIVELY |
| 01/06/2010 | CN101619057A N-substituted piperidine derivatives as serotonin receptor agents |
| 01/06/2010 | CN100578219C Detection method for Chinese medicine injection made from radix salvia miltiorrhiza and safflower |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577660C N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists used for the treatment of diabetes |
| 01/06/2010 | CN100577198C Medicine for curing cardio-cerebrovascular disease |
| 01/06/2010 | CN100577192C Medicine preparation for stagnate-removing and pulse-restoring |
| 01/06/2010 | CN100577188C Chinese medicine composition for treating heart failure and its preparation process |
| 01/06/2010 | CN100577184C Medicine composition and use thereof |
| 01/06/2010 | CN100577182C Emulsion containing aucklandia root oil, its preparation process and use |
| 01/06/2010 | CN100577174C Compositions containing defined oxidized phospholipids |
| 01/06/2010 | CN100577171C Medicament for treating severe heart failure |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/06/2010 | CN100577169C Pulse controlled releasing Urapidil tablet and its preparing method |
| 01/06/2010 | CN100577167C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 01/06/2010 | CN100577162C Substituted oxazolidinones for combinational therapy |
| 01/06/2010 | CN100577159C Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases and preparation method thereof |
| 01/06/2010 | CN100577158C Method for preparing Tengchasu dispersibletablet and its use |
| 01/06/2010 | CN100577153C Persimmon leaf extract controlled slow-release preparation and its preparation method |
| 01/06/2010 | CN100577152C 一种氯沙坦钾氢氯噻嗪片及其制备方法 One kind of losartan potassium and hydrochlorothiazide tablets prepared |
| 01/05/2010 | US7642378 Lipid lowering biphenylcarboxamides |
| 01/05/2010 | US7642362 Compounds as semaphorin inhibitors |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642286 Stable pharmaceutical compositions containing pravastatin |
| 01/05/2010 | US7642284 Luminacin analogs and uses thereof |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642262 Arylipiperdinopropanol and arylipiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641643 Methods and compositions to treat myocardial conditions |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2322168C Method for treating painful conditions of the anal region and compositions therefor |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326510 Drug Delivery Methods and Systems |
| 12/31/2009 | US20090326248 for treatment of insulin-like growth factor-1 receptor (IGF-1R) dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly; preferred compound is picropodophyllin |
| 12/31/2009 | US20090326221 New oxabispidine compunds useful in the treatment of cardiac arrhythmias |
| 12/31/2009 | US20090326218 Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents |
| 12/31/2009 | US20090326067 Levodopa Prodrug Mesylate, Compositions Thereof, and Uses Thereof |
| 12/31/2009 | US20090326053 Diagnostic uses of follistatin-like 1 |
| 12/31/2009 | US20090326052 Promoters exhibiting endothelial cell specificity and methods of using same |
| 12/31/2009 | US20090326042 Compounds and methods for modulating expression of crp |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326033 Carvedilol |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090326025 New pharmaceutical composition |
| 12/31/2009 | US20090325997 Pharmaceutical Compositions For The Treatment Of Capillary Arteriopathy |
| 12/31/2009 | US20090325989 Indazolyl derivatives useful as potassium channel modulating agents |
| 12/31/2009 | US20090325988 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof |
| 12/31/2009 | US20090325983 New purine derivatives |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325976 Prostacyclin derivatives |
| 12/31/2009 | US20090325970 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 12/31/2009 | US20090325944 Methods and Compositions for Modulating Glycosylation |
| 12/31/2009 | US20090325930 Selective estrogen receptor modulator |
| 12/31/2009 | US20090325925 Thiophenes and uses thereof |
| 12/31/2009 | US20090325918 Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action |
| 12/31/2009 | US20090325896 Partial and full agonists of a1 adenosine receptors |
| 12/31/2009 | US20090325873 Human glp-1 mimetibodies, compositions, methods and uses |
| 12/31/2009 | US20090325865 Liquid Formulations of Pegylated Growth Hormone |
| 12/31/2009 | US20090325289 Process for the multiplication of stem cells |
| 12/31/2009 | US20090324745 Compositions and methods for nutrition supplementation |
| 12/31/2009 | US20090324710 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 12/31/2009 | US20090324706 Nanostructures Suitable for Sequestering Cholesterol and Other Molecules |
| 12/31/2009 | US20090324624 Chitin micro-particles as an adjuvant |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | US20090324569 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 12/31/2009 | US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate |
| 12/30/2009 | WO2009158007A2 Methods and compositions for therapeutic treatment |
| 12/30/2009 | WO2009158005A1 Benzazepinone compounds |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2009157018A2 Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |
| 12/30/2009 | WO2009156484A2 Organic compounds |
| 12/30/2009 | WO2009156462A2 Organic compounds |
| 12/30/2009 | WO2009156284A1 Novel substituted pyridin-2-ones and pyridazin-3-ones |
| 12/30/2009 | WO2009156161A1 Pharmaceutical compositions comprising aminoadamantane derivatives |
| 12/30/2009 | WO2009156151A1 Mesoangioblast-like cell as well as methods and uses relating thereto |
| 12/30/2009 | WO2009156100A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 12/30/2009 | WO2009156099A1 6-substituted isoquinolines and isoquinolinones |
| 12/30/2009 | WO2009156092A2 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 12/30/2009 | WO2009156089A1 Diaryl ureas for treating heart failure |
| 12/30/2009 | WO2009156082A1 Oxazolidinones for the treatment of chronic obstructive pulmonary disease (copd) and/or asthma |
| 12/30/2009 | WO2009156072A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof |
| 12/30/2009 | WO2009156070A1 Diaryl urea for treating heart failure |
| 12/30/2009 | WO2009155669A1 Method of treatment of vascular complications |
| 12/30/2009 | WO2009136995A3 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 12/30/2009 | WO2009133458A4 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels |
| 12/30/2009 | WO2009034541A9 Controlled release pharmaceutical dosage forms of trimetazidine |
| 12/30/2009 | EP2138572A1 Mesoangioblast-like cell as well as methods and uses relating thereto |
| 12/30/2009 | EP2138497A1 Novel adenine compound |
| 12/30/2009 | EP2138489A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same |